Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Oncomed Pharma (OMED)

Oncomed Pharma (OMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oncomed Pharma 800 Chesapeake Drive Redwood City CA 94063 USA

P: 650-995-8200 F: 650-298-8600

Description:

OncoMed Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the discovering and developing monoclonal antibody therapeutics for cancer stem cells. It utilizes its technologies to identify, isolate and evaluate CSCs, validate multiple potential targets and pathways critical to CSC self-renewal and differentiation and develop antibody and other protein-based therapeutics. The company serves the healthcare industry and cancer therapy patients. OncoMed Pharmaceuticals, Inc. is based in Redwood City, United States.

Key Statistics

Overview:

Market Capitalization, $K 34,434
Shares Outstanding, K 38,690
Annual Sales, $ 44,420 K
Annual Net Income, $ -8,100 K
Last Quarter Sales, $ 10,180 K
Last Quarter Net Income, $ -4,670 K
60-Month Beta 1.86
% of Insider Shareholders 20.32%
% of Institutional Shareholders 45.16%
Float, K 30,828
% Float 79.68%

Growth:

1-Year Return -68.15%
3-Year Return -92.82%
5-Year Return -96.70%
5-Year Revenue Growth 17.58%
5-Year Earnings Growth 91.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/14/19
Earnings Per Share ttm -0.16
EPS Growth vs. Prev Qtr -143.75%
EPS Growth vs. Prev Year -128.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

OMED Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.76
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -13.14
Return-on-Assets (Before Tax) -7.73
Profit Margin % -18.24
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 0.82
Price/Cash Flow N/A
Price/Book 0.71
Book Value/Share 1.25
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar